NCT03392181进行中（未招募）早期 1 期
PET/MRI for the Staging of Newly Diagnosed Prostate Cancer
适应症
干预措施
相关药物
试验速览
- 阶段
- 早期 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 48
- 试验地点
- 1
- 主要终点
- PET/MR versus mp-MRI for the Staging of Newly Diagnosed Prostate Cancer
研究概览
简要总结
The purpose of this study is to gain understanding of how PET-MR (positron emission tomography-magnetic resonance imaging) using the substance 18F-DCFPyL (PyL) may help in diagnosing prostate cancer and in determining the stage of prostate cancer before surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 89 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
18F-DCFPyL
Experimental
干预措施: 18F-DCFPyL (Drug)
结局指标
主要结局
PET/MR versus mp-MRI for the Staging of Newly Diagnosed Prostate Cancer
时间窗: 5 years
To determine if PSMA-Targeted PET/MRI improves pre-operative staging of prostate cancer prior to radical prostatectomy compared to MRI alone.
次要结局
未报告次要终点
研究者
Edward Schaeffer
Chair, Department of Urology, Program of Director for GU Oncology
Northwestern University
研究点 (1)
Loading locations...
相似试验
招募中
早期 1 期
18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: A Pilot StudyProstate CancerNCT05707182University of Alabama at Birmingham30
已完成
1 期
A Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate CancerHealthy Male SubjectsSuspected Prostate CancerNCT06472531Yunhe Pharmaceutical (Tianjin) Co., Ltd32
Unknown
1 期
PET-CT/MRI in the Radiotherapy for Prostate CancerProstate CancerNCT02816840Xuzhou Medical University90
进行中（未招募）
2 期
Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer OutcomesProstate AdenocarcinomaNCT03762759Emory University140
招募中
不适用
Diagnostic Performance of PET Imaging for Prostate Specific Membrane Antigen (PSMA)Prostate cancerJPRN-UMIN000037697Osaka University Graduate School of Medicine250